Valion Bio, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Valion Bio, Inc. (VBIO) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $7.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-30
- Valion Bio, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $7.00K, a 30.00% decline from fiscal 2024.
- Valion Bio, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $10.00K.
- Valion Bio, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $62.00K, a 210.00% increase from fiscal 2021.
- Valion Bio, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $20.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $7.00K 10-K · filed 2026-03-30 |
| 2024-12-31 | $10.00K 10-K · filed 2026-03-30 |
| 2022-12-31 | $62.00K 10-K · filed 2024-03-25 |
| 2021-12-31 | $20.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |